This Healthtech start-up is ready to disrupt the industry with a 360-degree-complete solution for your health problems
Oxygenta is a preventive healthcare platform providing end-to-end solutions. They provide services such as predictive assessment, early diagnosis, and preventive measures for common lifestyle diseases such as hypertension, diabetics, and obesity. Their goal is to build the best healthcare solution platform in India. Affordable healthcare no longer means low-quality healthcare. Since wireless networks now reach over 80 percent of India’s population, Oxygenta has the potential to revolutionize the delivery of essential healthcare to those who previously had little or no access.
1 out of 3 people will be diagnosed with cancer in their lifetime, 500 million people suffer from respiratory diseases, 400 million people worldwide have diabetes, and an estimated 1 billion adults have hypertension. It’s not sufficient to just wait until people get sick and then have acute care in the emergency room and try to fix it. Even a car has predictive analytics where they do maintenance before the car breaks down, so there is a clearly need to change the game in the world of health and healthcare.
Saurabh Bajpayee is the founder of Oxygenta Healthcare. His education background is in B. Tech Chemical Engineering from Vishwakarma Institute of Technology Pune (2018 Pass out). His Specialties are in Digital Health Solutions, Intelligent Innovation, Strategic Planning, Healthcare Tech. Apart from this, he is also an Investor & Multi asset trader. He invests in small & medium start-ups. Through the performance of high-quality trials, Oxygenta Healthcare will be rigorously evaluated for impact and to identify barriers and facilitators to widespread uptake. “We will directly measure improvements in health, the use of resources to deliver such improvements, and the acceptability of Oxygenta Health to patients, communities, healthcare providers, and administrators. Changing the profile of diseases, life expectancy is increasing, new diseases are coming up are more fundamental problems of delivering healthcare. But we identified outcome as an important issue when the fact that patients need to be far more aware of the medical challenges that they are facing in order to solve them before they actually reach the door of the hospital,” said Saurabh.
Oxygenta has the potential to revolutionize the delivery of essential healthcare to those who previously had little or no access. Over the next few years, they are expected to deliver major improvements in access to quality affordable healthcare for people with high blood pressure and heart disease.
In the initial stage, in 2018, they had to overcome the challenge of market acceptance and at that stage their focus was only on matching the business opportunity with skills, experience and passion. During the growth phase in 2019, the biggest challenge was to ensure steady business growth in competitive market and now in 2020-2021, they are facing challenges in partnerships with MNC’s. They overcame challenge of steady business growth by focusing on customer retention.
Oxygenta is a self-funded start-up, with plans to acquire new businesses in the same domain. Their future goal is to focus on providing quality and affordable healthcare at each doorstep in the country.
His view of the start-up community in India is, “Currently India is the world’s third largest start-up ecosystem in the world with Bangalore ranking only behind London & Silicon Vally for greatest number of technology start-ups and 5 lakhs+ jobs created by more than 39K start-ups in India. In recent times, government has taken several measures to support start-up ecosystem in India by simplifying regulations, income tax exemptions and setting up 10000 Cr Fund for start-ups operated by SIDBI. Start-up Yatra is one of the good initiatives started by government.”
“Founders should not focus on funding, instead of focusing on funding they should focus on their customers. The biggest challenge is an undue focus on funding. The mindset that it is only funding that define success of start-up is dangerous. I believe that, every crisis comes with an opportunity. The shadow of the crisis will convert into the light. We should consider this pandemic as an opportunity and we all need to trust our ability and think of ways for repairing the damage and take one step at a time to get our company back to how it was before the pandemic,” is his valuable advice for young entrepreneurs and upcoming start-ups.
You can check out Oxygenta Healthcare at: www.oxygenta.in